N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	WASHC4 Gene (Entity type)	0.0057745385
N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	SCD Gene (Entity type)	0.0060973736
N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	MAGEA3 Gene (Entity type)	0.0071245776
N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	MAOA Gene (Entity type)	0.0049920003
N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Atrial Fibrillation Disease or Phenotype (Entity type)
N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	NRN1 Gene (Entity type)	-0.0042992574
N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	G0S2 Gene (Entity type)	0.0042948187
N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	MMD Gene (Entity type)	0.0045125727
N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	bupropion Compound (Entity type)	0.4127234518527984
N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	CXCL5 Gene (Entity type)	-0.0042292397

N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
WASHC4
Gene (Entity type)
0.0057745385

N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
SCD
Gene (Entity type)
0.0060973736

N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
MAGEA3
Gene (Entity type)
0.0071245776

N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
MAOA
Gene (Entity type)
0.0049920003

N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Atrial Fibrillation
Disease or Phenotype (Entity type)

N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
NRN1
Gene (Entity type)
-0.0042992574

N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
G0S2
Gene (Entity type)
0.0042948187

N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
MMD
Gene (Entity type)
0.0045125727

N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
bupropion
Compound (Entity type)
0.4127234518527984

N-{2-Butyl-3-[4-(3-dibutylamino-propoxy)-benzoyl]-benzofuran-5-yl}-methanesulfonamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
CXCL5
Gene (Entity type)
-0.0042292397

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.